Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07823452 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Supplementation of Gut-brain Axis (GLP-1)-Activating Carbohydrates for Increasing Satiety in Adolescents With Obesity

Name: Supplementation of Gut-brain Axis (GLP-1)-Activating Carbohydrates for Increasing Satiety in Adolescents With Obesity — clinical trial record (NCT07823452)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GUT BOOST

StatusNot Yet Recruiting

PhasePhase 2

SponsorIndiana University

Started2026-10-01

View on ClinicalTrials.gov ↗

Indiana University

306 trials monitored

See 37 trials at risk

Obesity

3,515 trials monitored

See 131 trials at risk

Glucagon-like peptide (GLP1) drugs have quickly become a standard treatment for the adults with obesity. These drugs target the appetite control center of the brain, which clows the rate of stomach emptying, and makes a person feel full. The researchers are exploring this response in children. This study is being conducted to better understand how two food carbohydrates affect the appetite control center of the brain. The investigators want to see if a special carbohydrate powder that is mixed with 1 cup of water twice a day will appetite.

Trial Details

NCT Number	NCT07823452
Lead Sponsor	Indiana University
Conditions	Obesity & Overweight
Enrollment	62 participants
Start Date	2026-10-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-16